Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers

NCT02162732 is registered in ClinicalTrials.gov with Giselle Sholler as lead sponsor.

NCT NCT02162732
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02162732 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Lead sponsor
Giselle Sholler
Phase
Not applicable
Overall status
Completed
Start date
July 8, 2014
Completion date
January 18, 2024
Enrollment
186 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

choroid plexus neoplasms, clear cell sarcoma, craniopharyngioma, dysembryoplastic neuroepithelial tumor, ependymoma, ewings sarcoma, germ cell tumors, glioma, liver tumors, malignant rhabdoid tumor, medulloblastoma, meningioma, neuroblastoma, non-rhabdomyosarcoma, osteosarcoma, primitive neuroectodermal tumors (pnets), renal cell carcinoma, rhabdomyosarcoma, wilms tumor